VASCULAR HYALINOSIS

VASCULAR HYALINOSIS was reported 85 times

VASCULAR HYALINOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antimetabolite Immunosuppressant [EPC] 11 0.0005
1 Selective T Cell Costimulation Blocker [EPC] 2 0.0004
2 Glinide [EPC] 3 0.0003
3 Sulfone [EPC] 3 0.0003
4 Calcineurin Inhibitor Immunosuppressant [EPC] 15 0.0001
5 Central alpha-2 Adrenergic Agonist [EPC] 6 0.0001
6 B Lymphocyte Stimulator-specific Inhibitor [EPC] 3 0.0001
7 Lipid-based Polyene Antifungal [EPC] 1 0.0001
8 Vitamin D3 Analog [EPC] 1 0.0000
9 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
10 Interleukin-6 Receptor Antagonist [EPC] 6 0.0000
11 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
12 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 4 0.0000
13 Calcium [EPC] 6 0.0000
14 Androgen [EPC] 1 0.0000
15 Corticosteroid [EPC] 47 0.0000
16 Purine Antimetabolite [EPC] 3 0.0000
17 Kinase Inhibitor [EPC] 16 0.0000
18 CD20-directed Cytolytic Antibody [EPC] 8 0.0000
19 Polyene Antifungal [EPC] 1 0.0000
20 Expectorant [EPC] 5 0.0000
21 Complement Inhibitor [EPC] 1 0.0000
22 Dihydropyridine Calcium Channel Blocker [EPC] 4 0.0000
23 HMG-CoA Reductase Inhibitor [EPC] 4 0.0000
24 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
25 Loop Diuretic [EPC] 4 0.0000
26 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
27 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
28 Fluoroquinolone Antibacterial [EPC] 1 0.0000
29 Azole Antifungal [EPC] 1 0.0000
30 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
31 Platelet Aggregation Inhibitor [EPC] 3 0.0000
32 Nonsteroidal Anti-inflammatory Drug [EPC] 4 0.0000
33 Vitamin C [EPC] 1 0.0000
34 Proton Pump Inhibitor [EPC] 1 0.0000
35 Tumor Necrosis Factor Blocker [EPC] 1 0.0000